why choose us

First received: December 14, 2022

Clinical Trial: Sugammadex as Rescue Therapy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Neuromuscular Blockade

Study Type: INTERVENTIONAL


Official Title: The Use of Sugammadex as Rescue Therapy Following Inadequate Reversal With Neostigmine

Brief Summary: Neuromuscular blocking agents (NMBAs) are commonly used in the practice of anesthesiology for skeletal muscle relaxation to facilitate tracheal intubation, mechanical ventilation, and to provide optimal surgical conditions.In order to prevent residual NMB, it is vital to adequately reverse any use of a non-depolarizing NMBA.This was historically done using an anticholinesterase such as neostigmine, which would increase the concentration of acetylcholine at the neuromuscular junction leading to the return of…

Read more